Visit WTR Logo
Click here to see our best subscription offers

International

Time is running out to nominate the world’s leading IP strategists

There is not much time left to make nominations for the 2019 edition of IAM Strategy 300, our exclusive guide on the world's best IP strategists.

Time is running out to nominate the world’s leading IP strategists
16 Nov 2018

How Dolby uses IP to turn world class innovation into bottom line returns

The inside track on a 50-year exercise in managing a multi-dimensional value creation strategy that keeps on delivering successful results

26 Oct 2018

Cannabis food and drink patent war on the horizon as sector set to boom

Data analysis reveals sparsely populated IP landscape and, with many big companies yet to enter the fray, “once-in-a-generation” opportunities for innovators

Latest

View all
15 Nov 2018

The big life sciences IP developments from October 2018

Cannabis patent war looming, “New NAFTA” set to benefit biopharma innovators, a blow for medical device inventors at the CJEU, and much more in this round-up of October’s big life sciences IP news Read more

23 Oct 2018

New initiative can help answer patent system criticisms, says Novartis’ IP policy chief

In an exclusive interview with IAM, Corey Salsberg sung the praises of the Pat-INFORMED database and predicted more to come for the platform Read more

17 Oct 2018

Are engineered nanoparticles a potential means of controlling release in drug delivery systems?

Choosing the most suitable route for administering drugs is of unquestionable importance. Therefore, researchers are suggesting new approaches for the development of drug delivery systems. Read more

17 Oct 2018

CRISPR: the anatomy of a patent landscape

A deep dive into a potentially game-changing technology provides important insights not only for patent professionals, but also for their colleagues in various other business-critical roles Read more

Refine content by:

Finance

View all
9 Oct 2018

Who are the world's leading IP strategists? The IAM Strategy 300 nomination process begins

The research process for the 2019 edition of IAM Strategy 300 starts today: let us know who you consider to be a world leading IP strategist. Read more

FRAND/SEPS

View all
9 Oct 2018

Who are the world's leading IP strategists? The IAM Strategy 300 nomination process begins

The research process for the 2019 edition of IAM Strategy 300 starts today: let us know who you consider to be a world leading IP strategist. Read more

24 Sep 2018

The world's top IP dealmakers and value creators identified – part three

We reveal who is listed in positions 20 to 11 in this year's IAM Market Makers ranking of the individuals who drive the global IP market. Read more

Law & Policy

View all
13 Sep 2018

Chinese biotech patents fail to make mark, more litigation for AbbVie, AIDS Heath Foundation appeals to SCOTUS and much more

The August edition of our monthly round-up of the life sciences stories you need to know Read more

9 Aug 2018

US pharma companies under increasing legislative pressure, key EU SPC decision and much more in July’s life sciences IP round-up

In this month’s round-up of patent news from the life sciences, we report on the latest blow to the St Regis Mohawks’ attempt shield their Restasis patents from inter partes review, the new bill seeking to roll out compulsory licensing in the US,… Read more

7 Jul 2018

All the big legal, market and deals news from the life sciences sector in June

In June’s round-up of life sciences-related news, we report on the US Supreme Court’s decision to grant certiorari in the Helsinn Healthcare v Teva Pharmaceuticals Section 102 dispute, but not in the Cleveland Clinic’s Section 101 case against True… Read more

10 Jun 2018

All the big life sciences patent news from May

In May’s round-up of life sciences-related patent news, we report on new research revealing a sharp surge in CRISPR patent filings in Asia, on mistaken claims that China has introduced a new 25-year pharma patent term and on the data showing the… Read more

Litigation

View all
9 Oct 2018

Who are the world's leading IP strategists? The IAM Strategy 300 nomination process begins

The research process for the 2019 edition of IAM Strategy 300 starts today: let us know who you consider to be a world leading IP strategist. Read more

24 Sep 2018

The world's top IP dealmakers and value creators identified – part three

We reveal who is listed in positions 20 to 11 in this year's IAM Market Makers ranking of the individuals who drive the global IP market. Read more

13 Sep 2018

Chinese biotech patents fail to make mark, more litigation for AbbVie, AIDS Heath Foundation appeals to SCOTUS and much more

The August edition of our monthly round-up of the life sciences stories you need to know Read more

9 Aug 2018

US pharma companies under increasing legislative pressure, key EU SPC decision and much more in July’s life sciences IP round-up

In this month’s round-up of patent news from the life sciences, we report on the latest blow to the St Regis Mohawks’ attempt shield their Restasis patents from inter partes review, the new bill seeking to roll out compulsory licensing in the US,… Read more

Market Developments

View all
9 Oct 2018

Who are the world's leading IP strategists? The IAM Strategy 300 nomination process begins

The research process for the 2019 edition of IAM Strategy 300 starts today: let us know who you consider to be a world leading IP strategist. Read more

24 Sep 2018

The world's top IP dealmakers and value creators identified – part three

We reveal who is listed in positions 20 to 11 in this year's IAM Market Makers ranking of the individuals who drive the global IP market. Read more

4 Sep 2018

Predictions of 2018 pharma M&A surge fall flat, but patent licensing deals are at a record high

Despite forecasts of a sharp rise in pharma deal-making activity, it has proved to be a slow year on the M&A front. One reason may be that licensing partnerships are proving far more popular than many had expected. Read more

Non practising entities

View all
9 Oct 2018

Who are the world's leading IP strategists? The IAM Strategy 300 nomination process begins

The research process for the 2019 edition of IAM Strategy 300 starts today: let us know who you consider to be a world leading IP strategist. Read more

24 Sep 2018

The world's top IP dealmakers and value creators identified – part three

We reveal who is listed in positions 20 to 11 in this year's IAM Market Makers ranking of the individuals who drive the global IP market. Read more

Patent pools

View all
24 Sep 2018

The world's top IP dealmakers and value creators identified – part three

We reveal who is listed in positions 20 to 11 in this year's IAM Market Makers ranking of the individuals who drive the global IP market. Read more

Strategy

View all
9 Oct 2018

Who are the world's leading IP strategists? The IAM Strategy 300 nomination process begins

The research process for the 2019 edition of IAM Strategy 300 starts today: let us know who you consider to be a world leading IP strategist. Read more

24 Sep 2018

The world's top IP dealmakers and value creators identified – part three

We reveal who is listed in positions 20 to 11 in this year's IAM Market Makers ranking of the individuals who drive the global IP market. Read more

19 Sep 2018

Smartphone technology – a peek behind the screen

In the wake of Apple’s announcement of three new iPhone models last week, a look at the origins of the technologies that lie behind the devices. Read more

4 Sep 2018

Predictions of 2018 pharma M&A surge fall flat, but patent licensing deals are at a record high

Despite forecasts of a sharp rise in pharma deal-making activity, it has proved to be a slow year on the M&A front. One reason may be that licensing partnerships are proving far more popular than many had expected. Read more

Technology licensing

View all
9 Oct 2018

Who are the world's leading IP strategists? The IAM Strategy 300 nomination process begins

The research process for the 2019 edition of IAM Strategy 300 starts today: let us know who you consider to be a world leading IP strategist. Read more

24 Sep 2018

The world's top IP dealmakers and value creators identified – part three

We reveal who is listed in positions 20 to 11 in this year's IAM Market Makers ranking of the individuals who drive the global IP market. Read more

Trademarks

View all
26 Apr 2018

The inductees into the IP Hall of Fame for 2018 have been announced

A pioneer in Asia, a renowned US judge and the head of IP at one of the world’s most innovative companies are this year’s inductees into the IP Hall of Fame. Ella Cheong, Richard Linn and Kevin Rhodes were selected to join the pantheon by the IP… Read more

Valuation

View all
9 Oct 2018

Who are the world's leading IP strategists? The IAM Strategy 300 nomination process begins

The research process for the 2019 edition of IAM Strategy 300 starts today: let us know who you consider to be a world leading IP strategist. Read more

24 Sep 2018

The world's top IP dealmakers and value creators identified – part three

We reveal who is listed in positions 20 to 11 in this year's IAM Market Makers ranking of the individuals who drive the global IP market. Read more

4 Sep 2018

Predictions of 2018 pharma M&A surge fall flat, but patent licensing deals are at a record high

Despite forecasts of a sharp rise in pharma deal-making activity, it has proved to be a slow year on the M&A front. One reason may be that licensing partnerships are proving far more popular than many had expected. Read more

27 Jul 2018

Revolutionary change in CRISPR patent landscape poses tough questions for life sciences companies

The patent landscape for gene editing technology could be unrecognisable in just a few years, as grants grow exponentially and commercial applications accelerate.  Read more

Trending

1

Time is running out to nominate the world’s leading IP strategists

2

Cannabis food and drink patent war on the horizon as sector set to boom

3

CRISPR: the anatomy of a patent landscape

4

New initiative can help answer patent system criticisms, says Novartis’ IP policy chief

5

Are engineered nanoparticles a potential means of controlling release in drug delivery systems?

Find an expert

Mike Nicholls
Partner
London, United Kingdom
J A Kemp
View full biography
We use cookies on www.iam-media.com. By using this site, you agree that we may store and access cookies on your device. For further information please read our cookie policy and our terms and conditions.